Cresco Labs Inc.
CRLBF
$0.90
-$0.05-5.22%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 643.91M | 658.34M | 672.70M | 687.57M | 708.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 643.91M | 658.34M | 672.70M | 687.57M | 708.40M |
| Cost of Revenue | 320.03M | 331.28M | 344.93M | 345.72M | 354.93M |
| Gross Profit | 323.88M | 327.06M | 327.77M | 341.85M | 353.46M |
| SG&A Expenses | 229.24M | 229.77M | 228.50M | 234.05M | 237.92M |
| Depreciation & Amortization | 19.94M | 20.18M | 20.67M | 20.74M | 21.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 569.21M | 581.23M | 594.10M | 600.50M | 614.36M |
| Operating Income | 74.70M | 77.11M | 78.60M | 87.07M | 94.04M |
| Income Before Tax | -97.30M | -95.42M | -5.22M | 16.20M | -27.48M |
| Income Tax Expenses | 44.53M | 44.62M | 45.44M | 52.59M | 46.19M |
| Earnings from Continuing Operations | -141.82 | -140.04 | -50.66 | -36.38 | -73.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.78M | 4.64M | -1.54M | -9.30M | -10.01M |
| Net Income | -134.05M | -135.41M | -52.19M | -45.68M | -83.68M |
| EBIT | 74.70M | 77.11M | 78.60M | 87.07M | 94.04M |
| EBITDA | 122.72M | 125.83M | 130.45M | 141.00M | 150.71M |
| EPS Basic | -0.37 | -0.38 | -0.15 | -0.13 | -0.24 |
| Normalized Basic EPS | 0.07 | 0.07 | 0.04 | 0.03 | -0.07 |
| EPS Diluted | -0.37 | -0.38 | -0.15 | -0.13 | -0.24 |
| Normalized Diluted EPS | 0.07 | 0.07 | 0.04 | 0.03 | -0.07 |
| Average Basic Shares Outstanding | 1.43B | 1.42B | 1.41B | 1.40B | 1.39B |
| Average Diluted Shares Outstanding | 1.43B | 1.42B | 1.41B | 1.40B | 1.39B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |